Debra Quinn Kolodner1, Huong Do, Mary Cooper, Eliot Lazar, Mark Callahan. 1. Division of Outcomes and Effectiveness Research, Department of Medicine, Columbia University College of Physicians & Surgeons, Weill Medical College of Cornell, New York, NY, USA. daq1@columbia.edu
Abstract
BACKGROUND: Clinical guidelines support the use of preoperative B-blocker in select patients. Patient safety groups have sought to measure the level of adherence to these recommendations. OBJECTIVE: This study was performed to compare the utilization of preoperative B-blocker with current guidelines across multiple diverse institutions. DESIGN: Retrospective chart review was performed of inpatients undergoing noncardiac surgery across 5 hospital centers during 2003 to 2004. The primary outcome of interest was the administration of preoperative B-blocker. PARTICIPANTS: The study sample included 1,304 randomly selected patients meeting the guideline criteria for preoperative B-blockade. MEASUREMENTS AND MAIN RESULTS: Among patients meeting recommendations for preoperative B-blocker, only 44% (430/983) received B-blocker before surgery. Patients who had not previously received B-blocker were given B-blocker before surgery in only 14% (85/600) of cases. Target heart rates goals for perioperative B-blockade were achieved in 26% (113/430) of cases. Predictors for initiating preoperative B-blocker included nonelective surgery or a history of hypertension or diabetes. Individual hospitals were independently predictive of preoperative B-blocker administration in multivariable models. CONCLUSIONS: Preoperative B-blocker was significantly underutilized when compared with the current guideline recommendations. Target heart rate goals were not achieved in clinical practice, and few hospitalized patients had preoperative B-blockade initiated. The lack of adherence to preoperative B-blocker recommendations in practice may be impacted by ongoing clinical questions regarding the appropriate selection of candidates for this therapy. Further efforts toward achieving guideline recommendations for preoperative B-blocker use should be focused on the subset of patients that are uniformly agreed upon to be at high risk for cardiac events.
BACKGROUND: Clinical guidelines support the use of preoperative B-blocker in select patients. Patient safety groups have sought to measure the level of adherence to these recommendations. OBJECTIVE: This study was performed to compare the utilization of preoperative B-blocker with current guidelines across multiple diverse institutions. DESIGN: Retrospective chart review was performed of inpatients undergoing noncardiac surgery across 5 hospital centers during 2003 to 2004. The primary outcome of interest was the administration of preoperative B-blocker. PARTICIPANTS: The study sample included 1,304 randomly selected patients meeting the guideline criteria for preoperative B-blockade. MEASUREMENTS AND MAIN RESULTS: Among patients meeting recommendations for preoperative B-blocker, only 44% (430/983) received B-blocker before surgery. Patients who had not previously received B-blocker were given B-blocker before surgery in only 14% (85/600) of cases. Target heart rates goals for perioperative B-blockade were achieved in 26% (113/430) of cases. Predictors for initiating preoperative B-blocker included nonelective surgery or a history of hypertension or diabetes. Individual hospitals were independently predictive of preoperative B-blocker administration in multivariable models. CONCLUSIONS: Preoperative B-blocker was significantly underutilized when compared with the current guideline recommendations. Target heart rate goals were not achieved in clinical practice, and few hospitalized patients had preoperative B-blockade initiated. The lack of adherence to preoperative B-blocker recommendations in practice may be impacted by ongoing clinical questions regarding the appropriate selection of candidates for this therapy. Further efforts toward achieving guideline recommendations for preoperative B-blocker use should be focused on the subset of patients that are uniformly agreed upon to be at high risk for cardiac events.
Authors: M Zaugg; T Tagliente; E Lucchinetti; E Jacobs; M Krol; C Bodian; D L Reich; J H Silverstein Journal: Anesthesiology Date: 1999-12 Impact factor: 7.892
Authors: E Boersma; D Poldermans; J J Bax; E W Steyerberg; I R Thomson; J D Banga; L L van De Ven; H van Urk; J R Roelandt Journal: JAMA Date: 2001-04-11 Impact factor: 56.272
Authors: D Poldermans; E Boersma; J J Bax; I R Thomson; L L van de Ven; J D Blankensteijn; H F Baars; T I Yo; G Trocino; C Vigna; J R Roelandt; H van Urk Journal: N Engl J Med Date: 1999-12-09 Impact factor: 91.245
Authors: Javed Butler; Patrick G Arbogast; Rhonda BeLue; James Daugherty; Manoj K Jain; Wayne A Ray; Marie R Griffin Journal: J Am Coll Cardiol Date: 2002-11-06 Impact factor: 24.094
Authors: Robert B Schonberger; Carrie L Lukens; O Dicle Turkoglu; Jessica L Feinleib; Kenneth L Haspel; Matthew M Burg Journal: J Cardiothorac Vasc Anesth Date: 2012-03-13 Impact factor: 2.628
Authors: Robert B Schonberger; Adambeke Nwozuzu; Jill Zafar; Eric Chen; Simon Kigwana; Miriam M Monteiro; Jean Charchaflieh; Sophisa Sophanphattana; Feng Dai; Matthew M Burg Journal: J Am Soc Hypertens Date: 2018-02-06